Literature DB >> 2758353

Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus).

H P Van Bever1, W J Stevens.   

Abstract

In this study, we wanted to test the hypothesis that hyposensitization (HS) abrogates the late asthmatic reaction (LAR). We therefore selected 15 asthmatic children (subjects) sensitized to house dust mite (HDM), as proven by positive prick tests and/or specific IgE via the RAST. All children demonstrated a positive bronchial provocation test (BPT) to HDM; 14 showed a dual asthmatic reaction and one child showed an isolated LAR. All children were treated with anti-asthmatic drugs and received HS. They were rechallenged after 1 yr of HS while their anti-asthmatic medication was not changed, except for beta-agonists which were used only for relief of symptoms. Two BPTs, with a mean interval of 6.4 months, were also performed in eight asthmatic children (controls), who did not receive HS. In the controls, the same reaction pattern was observed during both BPTs. In the subjects, the LAR completely resolved in 5/15 after 1 yr of HS (P = 0.04). Furthermore, as a group, the subjects showed a less severe LAR after 1 yr of HS (expressed as mean fall of FEV1) (P less than 0.0001). The PD20 of the immediate asthmatic reaction (IAR) was the same as before HS was started, but the IAR was also less severe after 1 yr of HS (expressed as mean fall of FEV1) (P = 0.028). From these observations it is concluded that, in asthmatic children, HS may resolve and/or reduce the severity of the LAR. Although the PD20 of the IAR is not changed, the severity of the IAR is also reduced after 1 yr of HS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758353     DOI: 10.1111/j.1365-2222.1989.tb02405.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

Review 1.  Pharmacotherapy of childhood asthma. An inflammatory disease.

Authors:  H P Van Bever; W J Stevens
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

2.  Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

Authors:  V A Varney; Q A Hamid; M Gaga; S Ying; M Jacobson; A J Frew; A B Kay; S R Durham
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 3.  Impact of allergen immunotherapy in allergic asthma.

Authors:  Wenming Zhang; Chunrong Lin; Vanitha Sampath; Kari Nadeau
Journal:  Immunotherapy       Date:  2018-03-23       Impact factor: 4.196

Review 4.  Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.

Authors: 
Journal:  CMAJ       Date:  1995-05-01       Impact factor: 8.262

Review 5.  New insights into the mechanisms of immunotherapy.

Authors:  S R Durham
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

6.  Can Serum-Specific IgE/Total IgE Ratio Predict Clinical Response to Allergen-Specific Immunotherapy in Children Monosensitized to House Dust Mite?

Authors:  Gulbin Bingol Karakoc; Mustafa Yilmaz; Derya Ufuk Altıntaş; Seval Güneşer Kendirli
Journal:  J Allergy (Cairo)       Date:  2012-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.